Clinical trial
Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study
NCT04915300 is registered in ClinicalTrials.gov with Laval University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study
- Lead sponsor
- Laval University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2023
- Completion date
- March 31, 2025
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.